Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
作者： Veronika Bachanova , David I Marks , Mei-Jie Zhang , Hailin Wang , Marcos de Lima
DOI: 10.1038/LEU.2013.253
关键词: Hazard ratio 、 Philadelphia chromosome 、 Transplantation 、 Gastroenterology 、 Minimal residual disease 、 Internal medicine 、 Survival rate 、 Imatinib 、 Tyrosine-kinase inhibitor 、 Population 、 Medicine 、 Surgery
摘要: Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal …
elsevier.com
archives-ouvertes.fr
nature.com
sci-hub.se 
researchgate.net 参考文章(43)
J P Radich, M L Slovak, K J Kopecky, D Head, D H Boldt, A Lee, J Kirk, R Babu, F Appelbaum, P Kessler, Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction Leukemia. ,vol. 8, pp. 1688- 1695 ,(1994)
Benedetta Bartolozzi, Alberto Bosi, Cecilia Orsi, Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis. Cancer. ,vol. 109, pp. 2657- 2663 ,(2006) , 10.1002/CNCR.22406
Ted A. Gooley, Wendy Leisenring, John Crowley, Barry E. Storer, Estimation of failure probabilities in the presence of competing risks: new representations of old estimators Statistics in Medicine. ,vol. 18, pp. 695- 706 ,(1999) , 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O
A Camera, A Vitale, C Quintarelli, M Picardi, G Specchia, M Mancini, A Cuneo, C Mecucci, G Martinelli, G Saglio, B Rotoli, F Mandelli, F Salvatore, R Foà, F Pane, , G Cimino, B Izzo, Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia. Leukemia. ,vol. 19, pp. 628- 635 ,(2005) , 10.1038/SJ.LEU.2403683
Mohamad Mohty, Myriam Labopin, Liisa Volin, Alois Gratwohl, Gérard Socié, Jordi Esteve, Reza Tabrizi, Arnon Nagler, Vanderson Rocha, , Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood. ,vol. 116, pp. 4439- 4443 ,(2010) , 10.1182/BLOOD-2010-02-266551
H Pfeifer, , B Wassmann, W Bethge, J Dengler, M Bornhäuser, M Stadler, D Beelen, V Vucinic, T Burmeister, M Stelljes, C Faul, P Dreger, A Kiani, K Schäfer-Eckart, R Schwerdtfeger, E Lange, B Kubuschok, H A Horst, M Gramatzki, P Brück, H Serve, D Hoelzer, N Gökbuget, O G Ottmann, Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia. Leukemia. ,vol. 27, pp. 1254- 1262 ,(2013) , 10.1038/LEU.2012.352
Adrienne de Labarthe, Philippe Rousselot, Françoise Huguet-Rigal, Eric Delabesse, Francis Witz, Sébastien Maury, Delphine Réa, Jean-Michel Cayuela, Marie-Christine Vekemans, Oumedaly Reman, Agnès Buzyn, Arnaud Pigneux, Martine Escoffre, Yves Chalandon, Elizabeth MacIntyre, Véronique Lhéritier, Jean-Paul Vernant, Xavier Thomas, Norbert Ifrah, Hervé Dombret, , Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia - Results of the GRAAPH-2003 study Blood. ,vol. 109, pp. 1408- 1413 ,(2007) , 10.1182/BLOOD-2006-03-011908
J.-M. Ribera, A. Oriol, M. Gonzalez, B. Vidriales, S. Brunet, J. Esteve, E. del Potro, C. Rivas, M.-J. Moreno, M. Tormo, V. Martin-Reina, J. Sarra, R. Parody, J. P. de Oteyza, E. Bureo, M.-T. Bernal, , Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial Haematologica. ,vol. 95, pp. 87- 95 ,(2010) , 10.3324/HAEMATOL.2009.011221
Daniel Weisdorf, Stephen Spellman, Michael Haagenson, Mary Horowitz, Stephanie Lee, Claudio Anasetti, Michelle Setterholm, Rebecca Drexler, Martin Maiers, Roberta King, Dennis Confer, John Klein, Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biology of Blood and Marrow Transplantation. ,vol. 14, pp. 748- 758 ,(2008) , 10.1016/J.BBMT.2008.04.003
Giovanni Riva, Mario Luppi, Patrizia Barozzi, Chiara Quadrelli, Sabrina Basso, Daniela Vallerini, Eleonora Zanetti, Monica Morselli, Fabio Forghieri, Monica Maccaferri, Francesco Volzone, Cinzia Del Giovane, Roberto D'Amico, Franco Locatelli, Giuseppe Torelli, Patrizia Comoli, Leonardo Potenza, Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatment. Blood. ,vol. 115, pp. 1512- 1518 ,(2010) , 10.1182/BLOOD-2009-06-230391